LISATA THERAPEUTICS, INC. Deferred Tax Liabilities, Intangible Assets
LISATA THERAPEUTICS, INC. (LSTA) had Deferred Tax Liabilities, Intangible Assets of $1.07 million as of 2016-12-31, per its 10-K filed 2017-03-17.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Liabilities › Deferred Tax Liabilities, Net › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets · last filed 2017-03-17
- 2016-12-31: Deferred Tax Liabilities, Intangible Assets $1.07M.
- 2015-12-31: Deferred Tax Liabilities, Intangible Assets $932.70K.
- 2015-09-30: Deferred Tax Liabilities, Intangible Assets -$3.70M.
- 2015-06-30: Deferred Tax Liabilities, Intangible Assets -$3.70M.
| Period end | Deferred Tax Liabilities, Intangible Assets | Deferred Tax Liabilities, Intangible Assets as first filed |
|---|---|---|
| 2016-12-31 | $1.07M 10-K · filed 2017-03-17 | |
| 2015-12-31 | $932.70K 10-K · filed 2017-03-17 | |
| 2015-09-30 | -$3.70M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | -$3.70M 10-Q · filed 2015-08-06 | |
| 2014-12-31 | $18.18M 10-K · filed 2016-03-15 | |
| 2013-12-31 | $3.60M 10-K · filed 2016-03-15 | $4.38M 10-K · filed 2014-03-13 |
| 2012-12-31 | $3.60M 10-K · filed 2015-03-02 | $3.31M 10-K · filed 2013-03-11 |
| 2011-12-31 | $3.30M 10-K · filed 2013-03-11 | -$3.30M 8-K · filed 2012-08-15 |
| 2010-12-31 | $0.00 8-K · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |